As described above, in patients with severe asthma and an increased eosinophil count in the sputum or blood with frequent exacerbations, an anti-IL-5 Ab or an anti-IL-5R Ab reduces the blood eosinophil count and asthma exacerbation frequency [23]. Here, IL5RA is linked to asthma.